Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K. Fielding, Anthony H. Goldstone, Susan Richards et al.|Blood|2006Cited by 843
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H. Goldstone, Jacob M. Rowe, Susan Richards et al.|Blood|2007Cited by 782
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)Anthony V. Moorman, Christine J. Harrison, Susan Richards et al.|Blood|2006Cited by 221
Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemiaHoward L. McLeod, Brenda Gibson, Sally A. Coulthard et al.|British Journal of Haematology|1999Cited by 128
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)Steven P. Piccoli, Susan Kirshner, Devangi Mehta et al.|Bioanalysis|2019Cited by 94